The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd

Deutsche Bank Deutsche Bank AG, Hong Kong Branch Level 60 International Commerce Centre 1 Austin Road West Kowloon, Hong Kong SAR August 14, 2026 1. Department of Corporate Services, BSE Limited Floor 25, P J Towers, Dalal Street, Mumbai - 400 001 2. National Stock Exchange of lndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400 051 3. cc: Dr. Agarwal’s Health Care Limited 1st Floor, Buhari Towers, No. 4, Moores Road, off Greams Road, Near Asan Memorial School, Chennai, Tamil Nadu 600006 Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Dear Sir/Ma’am, We, Deutsche Bank Group (DB International Trust (Singapore) Limited) (“Offshore Security Agent”), are writing to you in our capacity as offshore security agent under the Facility Agreement (as defined below). A facility agreement dated March 26, 2024 (“Facility Agreement”) had been entered into between, inter alia, Hyperion Investments Pte. Ltd. (“Borrower”) and certain lenders for the purpose of availing a facility aggregating up to USD 100,000,000 (“Facility”) by the Borrower. In connection with the Facility, (i) security interest had been created on all the shares of the Borrower held by TPG Growth III SF Pte. Ltd. and TPG Growth V SF Markets Pte. Ltd., the shareholders of the Borrower (collectively, the “Shareholders”) in favour of the Offshore Security Agent, acting as the offshore security agent for the benefit of the lenders (including their assignees, transferees, successors and novatees, from time to time) pursuant to a borrower share charge dated March 26, 2024; and (ii) certain restrictions were imposed on the Borrower in relation to 73,193,988 equity shares (“Shares”) constituting approx. 23.09% of the issued and paid-up share capital of Dr. Agarwal’s Health Care Limited (“Target Company”) held by the Borrower. The Offshore Security Agent had previously made a disclosure on February 6, 2025 under Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the “Takeover Code”) in relation to the creation of the abovementioned encumbrances over the Shares of the Target Company held by the Borrower. Deutsche Bank Separately, the Borrower had also created a pledge over the Shares held by the Borrower in the Target Company in favour of Catalyst Trusteeship Limited (the “Onshore Security Agent”) acting as the onshore security agent for the benefit of the lenders (including their assignees, transferees, successors and novatees, from time to time) in the depository system on February 4, 2025, in accordance with the timelines under the Facility Agreement. The Onshore Security Agent had made a disclosure in relation to such pledge on February 6, 2025. The Borrower has undertaken a sale/disposal of 24,160,000 equity shares of the Target Company out of the total Shares held by the Borrower in the Target Company on August 12, 2026 following a partial release of pledge by the Onshore Security Agent over 31,698,303 equity shares out of the total Shares held by the Borrower in the Target Company on August 11, 2026 and pledged by the Borrower. Disclosures have been be filed by the Onshore Security Agent in relation to the foregoing on August 13, 2026. Enclosed is a disclosure under Regulation 29(2) of the Takeover Code in relation to the change in shareholding (in respect of which certain encumbrances had been created as mentioned hereinabove) from the last disclosure made by the Offshore Security Agent on February 6, 2025 under Regulation 29(1) of the Takeover Code by virtue of a sale/disposal by the Borrower of 24,160,000 equity shares out of the total Shares held by the Borrower in the Target Company. We request you to take the same on record and acknowledge the same. Yours faithfully, Signature of Authorised Signatory Name: RAMANATHAPURA, Prasanna Venkatesha Murthy Manu Designation: Vice President Place: Deutsche Bank AG, Hong Kong Branch Date: 14 August 2026 Chairman of the Supervisory Board: Alexander R. Wynaendts Management Board: Christian Sewing (Chairman), James von Moltke, Fabrizio Campelli, Marcus Chromik, Bernd Leukert, Alexander von zur Mühlen, Laura Padovani, Claudio de Sanctis, Rebecca Short Deutsche Bank Aktiengesellschaft domiciled in Frankfurt am Main; Local Court of Frankfurt am Main, HRB No 30 000; VAT ID No DE114103379; www.db.com Disclosure under Regulation 29(2) of SEBl (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Name of the Target Company Dr. Agarwal’s Health Care Limited (TC) Name(s) of the acquirer and DB International Trust (Singapore) Limited acting in its Persons Acting in Concert (PAC) capacity as the offshore security agent (the “Offshore with the acquirer Security Agent”) for certain lenders to Hyperion Investments Pte. Ltd. under the Facility Agreement (as defined below). Whether the acquirer belongs to No Promoter/Promoter group Name(s) of the Stock BSE Limited and National Stock Exchange of India Limited Exchange(s) where the shares of TC are Listed % w .r.t. % w.r.t. total total diluted share/voting Details of the share/voting Number capital acquisition/disposal as follows capital of the wherever applicable(*) (**) Before the acquisition/ Nil Nil Nil disposal under consideration, holding of: (a) Shares carrying voting rights (b) Shares in the nature of 73,193,988# 23.09# 22.93# encumbrance (pledge/ lien/ non-disposal undertaking/ others) (c) Voting rights (VR) Nil Nil Nil otherwise than by equity shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) (e) Total (a+b+c+d) 73,193,988# 23.09# 22.93# Details of Nil Nil Nil acquisition/sale/disposal (a) Shares carrying voting rights acquired / sold (b) VRs acquired / sold Nil Nil Nil otherwise than by shares (c) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired / sold (d) Shares encumbered / 24,160,000# 7.62# 7.57# invoked / released by the acquirer (e) Total (a+b+c+/-d) 24,160,000# 7.62# 7.57# After the Nil Nil Nil acquisition/sale/disposal, holding of: (a) Shares carrying voting rights (b) Shares encumbered with 49,033,988# 15.47# 15.36# the acquirer (c) VRs otherwise than by Nil Nil Nil shares (d) Warrants/convertible Nil Nil Nil securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) after acquisition (e) Total (a+b+c+d) 49,033,988# 15.47# 15.36# Mode of acquisition/sale (e.g. Sale/disposal following a partial release of encumbrance. open market / off-market / public Please see note # below. issue / rights issue / preferential allotment / inter se transfer etc.) Date of acquisition/ sale of 12 August 2026 shares/ VR or date of receipt of intimation of allotment of shares, whichever is applicable. Equity share capital / total voting 316,983,028 fully paid up equity shares of INR 1/- each capital of the TC before the said acquisition / sale Equity share capital/ total voting 316,983,028 fully paid up equity shares of INR 1/- each capital of the TC after the said acquisition / sale Total diluted share/voting capital 319,262,876 fully paid up equity shares of INR 1/- each of the TC after the said acquisition / sale Note # 1. A facility agreement dated March 26, 2024 (“Facility Agreement”) had been entered into between, inter alia, Hyperion Investments Pte. Ltd. (“Borrower”) and certain lenders for the purpose of availing a facility aggregating up to USD 100,000,000 (“Facility”) by the Borrower. In connection with the Facility, indirect encumbrance and encumbrance (by way of restrictions on the Borrower) had been created by TPG Growth III SF Pte. Lt [Showing first 8,000 characters — download PDF for full document]